Director Mark Demilio disposed of 2,254 shares on January 14th, generating proceeds of $495,880. Following the sale, his direct holding stands at 19,962 shares, valued at approximately $4,391,640. This transaction marks a 10.15% reduction in his stake and was disclosed in a filing with the Securities and Exchange Commission.

In the quarter ending December 11th, the company reported earnings per share of $1.71, missing consensus estimates by $0.42. Revenue reached $883.81 million, up 8.9% year-over-year and nearly matching analyst forecasts of $883.65 million. Net margin was 3.22%, while return on equity remained deeply negative at 161.72%. Sell-side forecasts now project full-year EPS of 4.39.

Morgan Stanley raised its target to $275, representing a substantial premium to the current consensus of $227.13 and reflecting confidence in sustained revenue growth. However, the six-month range of analyst estimates remains wide, with a median target near $200. Mixed ratings from major firms—nine Buy, eight Hold and four Sell—underscore divergent views on margin improvement and valuation re-rating.

Institutional investors held 90.17% of shares outstanding at year-end. Clearstead Advisors lifted its position by 713.3% to 122 shares in Q3, while BNP Paribas Asset Management initiated a $26,000 position in Q2. Huntington National Bank increased its stake by 87.8% to 139 shares, and Harvest Fund Management added a new $30,000 holding. These shifts reflect selective conviction among large funds ahead of the spring selling season.